# ImmunityBio, Inc.: Form 8-K, filed Apr 17, 2018

- Company: [ImmunityBio, Inc.](/companies/ibrx.md) (CIK 1326110)
- Form: 8-K
- Filed: 2018-04-17
- Accepted by EDGAR: Apr 17, 2018, 16:45 ET
- Period: 2018-04-16
- Accession: 0001193125-18-119869
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326110/000119312518119869/d561432d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326110/000119312518119869/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326110/000119312518119869/d561432d8k.htm

Filed Apr 17, 2018.
Source: SEC EDGAR, the filing index for accession 0001193125-18-119869. Last ingested by Listed: Nov 9, 2026, 17:45 ET. No prices; not investment advice.
